Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide maintenance after salvage immunochemotherapy in relapsed or refractory mantle cell lymphoma
2008-000678-19Phase 2Terminated
- Sponsor
- LMU Klinikum
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenalidomide in mantle cell lymphoma (MCL), sponsored by LMU Klinikum. Primary endpoint: Feasibility of lenalidomide maintenance. Started Sep 2009; status: terminated.
02
Drugs
lenalidomide
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2008-000678-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000678-19.